Vectors Research Management’s Vanguard FTSE Europe ETF VGK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.25M Sell
59,268
-2,132
-3% -$187K 1.37% 19
2026
Q1
$5.06M Buy
61,400
+43,046
+235% +$3.7M 1.48% 16
2025
Q4
$1.53M Buy
18,354
+1,489
+9% +$121K 0.47% 60
2025
Q3
$1.35M Buy
+16,865
New +$1.32M 0.42% 64
2021
Q4
Sell
-47
Closed -$3.18K 617
2021
Q3
$3K Hold
47
﹤0.01% 452
2021
Q2
$3K Buy
+47
New +$3.17K ﹤0.01% 470
2020
Q1
Sell
-47
Closed -$3K 563
2019
Q4
$3K Sell
47
-158
-77% -$8.83K ﹤0.01% 478
2019
Q3
$11K Buy
205
+1
+0.5% +$53 0.01% 281
2019
Q2
$11K Sell
204
-73,053
-100% -$3.98M 0.01% 265
2019
Q1
$3.93M Sell
73,257
-14,794
-17% -$773K 2.23% 11
2018
Q4
$4.28M Buy
88,051
+78,671
+839% +$4.05M 2.04% 8
2018
Q3
$5.45M Buy
+9,380
New +$531K 3.35% 6

Other funds holding VGK

Vectors Research Management's VGK Position: Q2 2026 in Review

Vectors Research Management reduced its Vanguard FTSE Europe ETF (VGK) stake by 3.5% in Q2 2026, selling an estimated $187K and leaving 59,268 shares worth $5.25M. The position accounts for 1.37% of the portfolio, ranked #19.

Vectors Research Management first reported a position in VGK in Q3 2018 and has held it in 12 quarters since. The position peaked at $5.45M in Q3 2018. 891 funds tracked by Wall St. Rank hold VGK as of Q2 2026.

  • Vectors Research Management held 59,268 shares of Vanguard FTSE Europe ETF worth $5.25M as of Q2 2026.
  • Vectors Research Management sold 2,132 Vanguard FTSE Europe ETF shares in Q2 2026, an estimated $187K.
  • Vanguard FTSE Europe ETF made up 1.37% of Vectors Research Management's portfolio in Q2 2026, its #19 holding.
  • Vectors Research Management first reported a position in Vanguard FTSE Europe ETF in Q3 2018 and has held it in 12 quarters since.
  • Vectors Research Management's Vanguard FTSE Europe ETF position peaked at $5.45M in Q3 2018.
  • 891 funds tracked by Wall St. Rank held Vanguard FTSE Europe ETF as of Q2 2026.

Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.